Peak V’O₂ is an independent predictor of survival in patients with cardiac amyloidosis

References

• Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583–596.
   PubMed Web of Science ®Google Scholar
• Kristen AV, Perz JB, Schonland SO, et al. Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis. J Heart Lung Transplant. 2007;26:1313–1319.
   PubMed Web of Science ®Google Scholar
• Dispenzieri A, Gertz MA, Kyle RA, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004;22:3751–3757.
   PubMed Web of Science ®Google Scholar
• Kristen AV, Brokbals E, Aus dem Siepen F, et al. Cardiac amyloid load: a prognostic and predictive biomarker in patients with light-chain amyloidosis. J Am Coll Cardiol. 2016;68:13–24.
   PubMed Web of Science ®Google Scholar
• Guazzi M, Cahalin LP, Arena R. Cardiopulmonary exercise testing as a diagnostic tool for the detection of left-sided pulmonary hypertension in heart failure. J Card Fail. 2013;19:461–467.
   PubMed Web of Science ®Google Scholar
• Arena R, Myers J, Aslam SS, et al. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J. 2004;147:354–360.
   PubMed Web of Science ®Google Scholar
• Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005;79:319–328.
   PubMed Web of Science ®Google Scholar
• Arena R, Myers J, Hsu L, et al. The minute ventilation/carbon dioxide production slope is prognostically superior to the oxygen uptake efficiency slope. J Card Fail. 2007;13:462–469.
   PubMed Web of Science ®Google Scholar
• Maurer M, Lousada I, Hanna M, et al. Recommendations from the Amyloidosis Research Consortium Educational Roundtable at the American College of Cardiology Annual Meeting, 1 April 2016. Amyloid 2017;24:165–166.
   PubMed Web of Science ®Google Scholar
• Sperry BW, Vranian MN, Hachamovitch R, et al. Subtype-specific interactions and prognosis in cardiac amyloidosis. J Am Heart Assoc. 2016;5:e002877.
   PubMed Web of Science ®Google Scholar
• Sachchithanantham S, Offer M, Venner C, et al. Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis. Haematologica 2015;100:1469–1476.
   PubMedGoogle Scholar
• Yuda S, Hayashi T, Yasui K, et al. Pericardial effusion and multiple organ involvement are independent predictors of mortality in patients with systemic light chain amyloidosis. Intern Med. 2015;54:1833–1840.
   PubMed Web of Science ®Google Scholar
• Keteyian SJ, Patel M, Kraus WE, et al. Variables measured during cardiopulmonary exercise testing as predictors of mortality in chronic systolic heart failure. J Am Coll Cardiol. 2016;67:780–789.
   PubMed Web of Science ®Google Scholar
• Clemmensen TS, Mølgaard H, Sörensen J, et al. Inotropic myocardial reserve deficiency is the predominant feature of exercise haemodynamics in cardiac amyloidosis. Eur J Heart Fail. 2017;19:1457–1465.
   PubMedGoogle Scholar
• Ong KC, Askew JW, Dispenzieri A, et al. Abnormal stress echocardiography findings in cardiac amyloidosis. Amyloid 2016;23:124–131.
   PubMed Web of Science ®Google Scholar
• Juneblad K, Näslund A, Olofsson BO, et al. Outcome of exercise electrocardiography in familial amyloidotic polyneuropathy patients, Portuguese type, under evaluation for liver transplantation. Amyloid 2004;11:208–213.
   PubMed Web of Science ®Google Scholar
• Nakanishi M, Takaki H, Kumasaka R, et al. Targeting of high peak respiratory exchange ratio is safe and enhances the prognostic power of peak oxygen uptake for heart failure patients. Circ J. 2014;78:2268–2275.
   PubMed Web of Science ®Google Scholar
• Mishra S, Guan J, Plovie E, et al. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol. 2013;305:H95–H103.
   PubMed Web of Science ®Google Scholar
• Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778–786.
   PubMed Web of Science ®Google Scholar
• Myers J, Oliveira R, Dewey F, et al. Validation of a cardiopulmonary exercise test score in heart failure. Circ Heart Fail. 2013;6:211–218.
   PubMed Web of Science ®Google Scholar
• Jaussaud J, Aimable L, Douard H. The time for a new strong functional parameter in heart failure: the VE/VCO2 slope. Int J Cardiol. 2011;147:189–190.
   PubMed Web of Science ®Google Scholar
• Bassett DR Jr, Howley ET. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc. 2000;32:70–84.
   PubMed Web of Science ®Google Scholar
• Shafiq A, Brawner CA, Aldred HA, et al. Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-,) project. Am Heart J. 2016;174:167–172.
   PubMed Web of Science ®Google Scholar
• Finocchiaro G, Haddad F, Knowles JW, et al. Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. JACC Heart Fail. 2015;3:408–418.
   PubMed Web of Science ®Google Scholar
• Chase PJ, Kenjale A, Cahalin LP, et al. Effects of respiratory exchange ratio on the prognostic value of peak oxygen consumption and ventilatory efficiency in patients with systolic heart failure. JACC Heart Fail. 2013;1:427–432.
   PubMed Web of Science ®Google Scholar
• Arena R, Humphrey R, Peberdy MA. Prognostic ability of VE/VCO2 slope calculations using different exercise test time intervals in subjects with heart failure. Eur J Cardiovasc Prev Rehabil. 2003;10:463–468.
   PubMedGoogle Scholar
• Toste A, Soares R, Feliciano J, et al. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope. Rev Port Cardiol. 2011;30:781–787.
   PubMedGoogle Scholar
• Trikas A, Rallidis L, Hawkins P, et al. Comparison of usefulness between exercise capacity and echocardiographic indexes of left ventricular function in cardiac amyloidosis. Am J Cardiol. 1999;84:1049–1054.
   PubMed Web of Science ®Google Scholar
• Witte KK, Clark AL. Is the elevated slope relating ventilation to carbon dioxide production in chronic heart failure a consequence of slow metabolic gas kinetics? Eur J Heart Fail. 2002;4:469–472.
   PubMed Web of Science ®Google Scholar